Literature DB >> 9562042

Does pregnancy influence the course of HIV infection? Evidence from two large Swiss cohort studies.

M Weisser1, C Rudin, M Battegay, D Pfluger, C Kully, M Egger.   

Abstract

The question whether the natural history of HIV infection in women is affected by pregnancy has not so far been convincingly answered. We used prospective cohort data to compare pregnant and nonpregnant HIV-infected women during follow-up within the Swiss HIV Cohort Study (SHCS) and the Swiss Collaborative HIV and Pregnancy Study (SCHPS). Pregnant women were eligible if a CD4 cell count had been made before conception had taken place. Additional inclusion criteria were a pregnancy completed to delivery during follow-up and an observation period of at least 6 months after delivery. Thirty-two women who fulfilled these criteria were compared with 416 controls, matched for age and CD4 cell count at entry, who had not been pregnant during follow-up. Mean follow-up time was 4.8 years for pregnant women and 3.6 years for controls. The rate of any AIDS-defining event was higher in pregnant women (rate ratio [RR] from Cox regression, 1.92; 95% confidence interval [CI], 0.80-4.64) but this did not reach statistical significance (p = .15). A statistically significant difference (p = .008) emerged only for one AIDS-defining event, recurrent bacterial pneumonia (RR, 7.98; 95% CI, 1.73-36.8). The rate of death was similar in the two groups (RR, 1.14; 95% CI, 0.48-2.72; p = .8). Our results thus indicate that, after taking CD4 cell counts before conception into account, acceleration of disease progression is inconsistent among HIV-infected women who become pregnant during follow-up.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9562042     DOI: 10.1097/00042560-199804150-00004

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr Hum Retrovirol        ISSN: 1077-9450


  12 in total

Review 1.  Fetal pharmacotherapy.

Authors:  Gideon Koren; Gil Klinger; Arne Ohlsson
Journal:  Drugs       Date:  2002       Impact factor: 9.546

Review 2.  Pneumonia and pregnancy.

Authors:  W S Lim; J T Macfarlane; C L Colthorpe
Journal:  Thorax       Date:  2001-05       Impact factor: 9.139

3.  Pregnancy and other factors associated with higher CD4+ T-cell counts at HIV diagnosis in Southeast Michigan, 1992-2002.

Authors:  Linda L Wotring; JoLynn P Montgomery; Eve D Mokotoff; Joseph N Inungu; Norman Markowitz; Lawrence R Crane
Journal:  MedGenMed       Date:  2005-03-15

4.  Pregnancy outcomes in women with advanced HIV infection in Italy.

Authors:  Silvia Baroncelli; Enrica Tamburrini; Marina Ravizza; Carmela Pinnetti; Serena Dalzero; Manuela Scatà; Alessandra Crepaldi; Giuseppina Liuzzi; Atim Molinari; Antonella Vimercati; Anna Maccabruni; Daniela Francisci; Elena Rubino; Marco Floridia
Journal:  AIDS Patient Care STDS       Date:  2011-09-23       Impact factor: 5.078

Review 5.  Gynecologic issues in the HIV-infected woman.

Authors:  Helen E Cejtin
Journal:  Infect Dis Clin North Am       Date:  2008-12       Impact factor: 5.982

6.  Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093.

Authors:  D Heather Watts; Jeong-Gun Park; Susan E Cohn; Song Yu; Jane Hitti; Alice Stek; Pamela A Clax; Laila Muderspach; Juan J L Lertora
Journal:  Contraception       Date:  2007-12-21       Impact factor: 3.375

7.  Hormonal Contraception, Pregnancy, Breastfeeding, and Risk of HIV Disease Progression Among Zambian Women.

Authors:  Kristin M Wall; William Kilembe; Lisa Haddad; Bellington Vwalika; Shabir Lakhi; Naw Htee Khu; Ilene Brill; Elwyn Chomba; Joseph Mulenga; Amanda Tichacek; Susan Allen
Journal:  J Acquir Immune Defic Syndr       Date:  2016-03-01       Impact factor: 3.731

8.  Effect of Pregnancy on Response to Antiretroviral Therapy in HIV-Infected African Women.

Authors:  Athena P Kourtis; Jeffrey Wiener; Caroline C King; Renee Heffron; Nelly R Mugo; Kavita Nanda; Maria Pyra; Deborah Donnell; Connie Celum; Jairam R Lingappa; Jared M Baeten
Journal:  J Acquir Immune Defic Syndr       Date:  2017-01-01       Impact factor: 3.731

9.  Antiretroviral therapy initiation before, during, or after pregnancy in HIV-1-infected women: maternal virologic, immunologic, and clinical response.

Authors:  Vlada V Melekhin; Bryan E Shepherd; Samuel E Stinnette; Peter F Rebeiro; Gema Barkanic; Stephen P Raffanti; Timothy R Sterling
Journal:  PLoS One       Date:  2009-09-09       Impact factor: 3.240

Review 10.  Pregnancy and susceptibility to infectious diseases.

Authors:  Elisabeth Sappenfield; Denise J Jamieson; Athena P Kourtis
Journal:  Infect Dis Obstet Gynecol       Date:  2013-07-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.